Appendix 2—table 20. “Bone-Rx” Cohort (Region=South), Patient Characteristics Pre/Post Match.
| "Bone-Rx" Cohort / Region=South Unmatched | "Bone-Rx" Cohort / Region=South Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-user | BP User | p-value | All | BP Non-user | BP User | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 178,118 | 100.0% | 17,232 | 9.7% | 160,886 | 90.3% | 34,280 | 100.0% | 17,140 | 50.0% | 17,140 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 490 | 0.3% | 16 | 0.1% | 474 | 0.3% | <0.001 | 31 | 0.1% | 16 | 0.1% | 15 | 0.1% | 1.00 |
| 21-40 | 1,313 | 0.7% | 136 | 0.8% | 1,177 | 0.7% | 262 | 0.8% | 134 | 0.8% | 128 | 0.7% | ||
| 41-50 | 3,866 | 2.2% | 445 | 2.6% | 3,421 | 2.1% | 884 | 2.6% | 444 | 2.6% | 440 | 2.6% | ||
| 51-60 | 27,389 | 15.4% | 2,296 | 13.3% | 25,093 | 15.6% | 4,574 | 13.3% | 2,290 | 13.4% | 2,284 | 13.3% | ||
| 61-70 | 61,038 | 34.3% | 5,142 | 29.8% | 55,896 | 34.7% | 10,271 | 30.0% | 5,129 | 29.9% | 5,142 | 30.0% | ||
| 71-80 | 56,126 | 31.5% | 5,521 | 32.0% | 50,605 | 31.5% | 10,990 | 32.1% | 5,493 | 32.0% | 5,497 | 32.1% | ||
| ≥81 | 27,896 | 15.7% | 3,676 | 21.3% | 24,220 | 15.1% | 7,268 | 21.2% | 3,634 | 21.2% | 3,634 | 21.2% | ||
| Gender | ||||||||||||||
| Female | 160,994 | 90.4% | 15,179 | 88.1% | 145,815 | 90.6% | <0.001 | 30,322 | 88.5% | 15,149 | 88.4% | 15,173 | 88.5% | 0.69 |
| Male | 17,124 | 9.6% | 2,053 | 11.9% | 15,071 | 9.4% | 3,958 | 11.5% | 1,991 | 11.6% | 1,967 | 11.5% | ||
| Insurance | ||||||||||||||
| Commercial | 66,332 | 37.2% | 7,042 | 40.9% | 59,290 | 36.9% | <0.001 | 14,052 | 41.0% | 7,007 | 40.9% | 7,045 | 41.1% | 0.95 |
| Dual | 14,829 | 8.3% | 769 | 4.5% | 14,060 | 8.7% | 1,523 | 4.4% | 769 | 4.5% | 754 | 4.4% | ||
| Medicaid | 23,492 | 13.2% | 1,843 | 10.7% | 21,649 | 13.5% | 3,639 | 10.6% | 1,829 | 10.7% | 1,810 | 10.6% | ||
| Medicare | 73,465 | 41.2% | 7,578 | 44.0% | 65,887 | 41.0% | 15,066 | 43.9% | 7,535 | 44.0% | 7,531 | 43.9% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 60,253 | 33.8% | 5,785 | 33.6% | 54,468 | 33.9% | 0.454 | 11,462 | 33.4% | 5,736 | 33.5% | 5,726 | 33.4% | 0.91 |
| Yes | 117,865 | 66.2% | 11,447 | 66.4% | 106,418 | 66.1% | 22,818 | 66.6% | 11,404 | 66.5% | 11,414 | 66.6% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 0.95 | 1.84 | 1.86 | 2.65 | 0.86 | 1.70 | <0.001 | 1.80 | 2.54 | 1.80 | 2.54 | 1.79 | 2.53 | 0.78 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.